Some symptoms get talked about at the dinner table. These rarely leave the bathroom. GSM is the name that ties them together, and a name makes them easier to raise with a doctor.
Genitourinary syndrome of menopause (GSM)
Dryness, burning, pain with sex, needing the toilet more often. Doctors group these under one name, GSM, and the guidelines treat it as worth treating.
The words and the guidance
- English
- Genitourinary syndrome of menopause (GSM)
- Also searched as
- vaginal atrophy, atrophic vaginitis, vulvovaginal atrophy, urogenital atrophy
- Urdu
- genitourinary symptoms، یعنی اندام نہانی کی خشکی اور پیشاب میں تبدیلی
- Roman Urdu
- genitourinary symptoms, yani andaam nihani ki khushki aur peshaab mein tabdeeli
- NICE NG23, the menopause guideline doctors in England follow, defines the group like this: "Genitourinary symptoms associated with menopause include vulvovaginal dryness, pain with sex, vulvovaginal discomfort or irritation, and discomfort or pain when urinating."
- NICE NG23 recommends offering vaginal estrogen to people with genitourinary symptoms, including those already on HRT, and reviewing it regularly (1.5.5), and says moisturisers and lubricants can be used with it, or on their own by women who cannot or would rather not use it (1.5.8 and 1.5.9).
- The PMS recommendations note that GSM and sexual symptoms are often under-reported, and that many Pakistani women may not mention them unless asked respectfully and in private (Table 1; 2.2).
What it is
Genitourinary syndrome of menopause, GSM for short, covers the changes that come to the vulva, the vagina and the bladder as estrogen falls. In plain words: vaginal dryness, burning or irritation, pain during sex, and bladder symptoms such as needing to go more often, needing to go urgently, or stinging when you pass urine.
You may also see it called vaginal atrophy or atrophic vaginitis. The Pakistan Menopause Society's recommendations say GSM replaced those older names.
The PMS recommendations place GSM in the first few years after the menopause. Women's Health Concern notes that some women notice dryness before then. It is common: the European Menopause and Andropause Society (EMAS) says it affects around half of women after the menopause.
What it can feel like
Women's Health Concern, the patient arm of the British Menopause Society, lists more than dryness and pain during sex: discomfort when sitting, standing, exercising or passing urine, whether or not you are having sex at all. A smear test that has become harder to get through. Discharge that turns more watery, or irritation and burning that feels like thrush.
The factsheet warns that treating it as thrush with remedies bought over the counter can make it much worse. It also says only a quarter of affected women seek treatment.
In Urdu there is barely an everyday word for any of this. Most women manage to say khushki, dryness, or takleef, discomfort, and leave the rest unsaid.
Why it happens
The PMS recommendations describe GSM as the set of changes linked to a fall in estrogen and other sex hormones. Women's Health Concern explains what that does to the tissue: without estrogen, the skin of the vulva and vagina becomes thinner and less elastic, makes less moisture, and is more easily damaged, so even gentle friction can hurt.
What the guidelines say about treatment
NICE NG23 sets out the options in order:
- Vaginal estrogen is the first thing NICE recommends offering, including to women already on HRT (1.5.5). It comes as a cream, a gel, a tablet, a pessary or a ring, and NICE asks doctors to choose the form together with the woman (1.5.7). See vaginal estrogen.
- NICE asks doctors to explain that "serious adverse effects are very rare", that the estrogen acts locally with only a minimal amount absorbed into the bloodstream, and that symptoms often come back when it is stopped, though it can be restarted (1.5.6).
- EMAS adds that vaginal estrogen may help prevent urine infections that keep coming back. NICE covers that use in its separate guideline on recurrent urinary tract infection (1.5.13).
- Moisturisers and lubricants can be used with vaginal estrogen or on their own, including by women who cannot or would rather not use a hormone (1.5.8 and 1.5.9). The British Menopause Society's statement on GSM also gives both as options, with moisturisers used regularly whether or not you are having sex.
- If those have not worked or are not tolerated, NICE lists vaginal prasterone, and ospemifene as a tablet for women who find a locally applied treatment impractical, for example because of disability (1.5.10 and 1.5.11).
- On lasers, NICE is direct: "Do not offer vaginal laser treatment for genitourinary symptoms associated with menopause unless as part of a randomised controlled trial" (1.5.20).
Women who have had breast cancer have a separate set of NICE recommendations, starting with non-hormonal treatments, and involving a breast cancer specialist for women on aromatase inhibitors.
When to see a doctor
If dryness, pain or bladder changes get in the way of sex, sleep, prayer or sitting comfortably, that is reason enough. Women's Health Concern suggests writing your symptoms down and handing the note over if saying them out loud feels impossible.
The PMS recommendations ask doctors to look further for persistent pain, urine infections that keep coming back or do not respond to treatment, blood in the urine, a prolapse, or leaking that affects your daily life (Table 4). Bleeding after sex, or any bleeding after your periods have stopped, is on its list of red flags that need checking (2.3).
Questions to ask your doctor
- Could my dryness, burning or bladder symptoms be GSM?
- Is vaginal estrogen an option for me, and which form would suit me: a cream, a gel, a tablet, a pessary or a ring?
- If I would rather not use a hormone, what else do the guidelines list?
- Could this be an infection instead, and do I need a test before I treat it?
Faith and family
Women's Health Concern names the strain this can put on a marriage, especially when a woman feels unable to explain why she is pulling away from intimacy. Knowing it is common, and has a name and a treatment, can make the conversation with a husband easier as well as the one with a doctor.
Women also ask whether a vaginal treatment affects their fast in Ramadan, or their ghusl and prayer. Those questions belong with a qualified scholar. When to use the treatment around sehri and iftar is a question for whoever prescribes it.
Track it
- Roshara's symptom score rates 27 symptoms in a few minutes, with no account. The total is something to take to your appointment. Take the symptom score
- Where am I? names the stage you might be in. Six questions. Take Where am I?
- Log it day by day in the tracker, with what came just before. It needs a free account. Open the tracker
Common questions
- Is GSM the same as vaginal dryness?
- Vaginal dryness is one part of it. The Pakistan Menopause Society describes GSM as the whole collection of changes linked to falling estrogen, from the vulva and vagina to the urethra and bladder, and says the name replaced older terms such as vaginal atrophy (1.5.2). (Source: Pakistan Menopause Society, Good Clinical Practice Recommendations for Menopause Care in Pakistan (JSOGP 16(2), 28 April 2026))
- Will it go away on its own?
- Usually not. The Pakistan Menopause Society's recommendations say GSM is commonly chronic and progressive, and may come back when treatment stops (Table 1). The Menopause Society agrees: unlike hot flushes, which usually ease with time, GSM generally gets worse without treatment. (Source: Pakistan Menopause Society, Good Clinical Practice Recommendations for Menopause Care in Pakistan (JSOGP 16(2), 28 April 2026))
- Can I keep using vaginal estrogen for years?
- EMAS says a woman who feels vaginal estrogen helps her should be able to keep using it long term. The Menopause Society says it can be considered at any age, and for as long as it is needed. (Source: European Menopause and Andropause Society, Menopause Essentials 2026: Vulvovaginal atrophy (July 2026))
- Is vaginal estrogen the same as taking HRT?
- Not quite. NICE NG23 explains that vaginal estrogen works locally and only a minimal amount reaches the bloodstream compared with HRT taken for the whole body (1.5.6). (Source: NICE NG23, Menopause: identification and management (last updated 15 April 2026))
Sources
- NICE NG23, Menopause: identification and management (last updated 15 April 2026)Section: 1.5.5 to 1.5.20, Genitourinary symptoms; Terms used · Opened 1 October 2026© NICE 2026 Menopause: identification and management. Available from www.nice.org.uk/guidance/ng23 All rights reserved. Subject to Notice of rights. NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.
- Pakistan Menopause Society, Good Clinical Practice Recommendations for Menopause Care in Pakistan (JSOGP 16(2), 28 April 2026)Section: 1.5.2; 2.2; 2.3; Tables 1, 2 and 4; 5.4 · Opened 1 October 2026
- British Menopause Society, Consensus statement: Genitourinary syndrome of menopause (GSM) (reviewed November 2025)Section: Non-hormonal lubricants and moisturisers; Vaginal estrogen · Opened 10 October 2026
- Women's Health Concern, Vaginal dryness factsheet (reviewed October 2023)Section: Whole factsheet · Opened 1 October 2026
- European Menopause and Andropause Society, Menopause Essentials 2026: Vulvovaginal atrophy (July 2026)Section: Introduction; Non-hormonal management; Topical vaginal estrogens · Opened 15 October 2026
- The Menopause Society (then The North American Menopause Society), The 2020 genitourinary syndrome of menopause position statement, Menopause 2020;27(9):976-992Section: Introduction · Opened 15 October 2026
- The Menopause Society (then The North American Menopause Society), The 2022 hormone therapy position statement, Menopause 2022;29(7):767-794Section: Duration of use, initiation after age 60 years, and discontinuation: key points · Opened 15 October 2026